Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated ...
Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...
In 20 years, 97% (2.5-97.5 percentile range: 96%-98%), 66% (61%-70%), 34% (30%-41%), and 15% (9%-18%) of the patients received first-line, second-line, third-line ...
Data and statistics from the federal government and academic researchers, including unemployment rates, crime rates, and people's perceptions of their society, provide the foundation for policymakers, ...
A new arXiv preprint research paper, Balancing Security and Privacy: The Pivotal Role of AI in Modern Healthcare Systems, ...
Enhertu showed better outcomes in HR-positive, HER2-negative breast cancer, while Trodelvy was more effective in HR-negative, HER2-null tumors when used first. Real-world data from over 4,000 patients ...
The appropriate duration of anticoagulation for venous thromboembolism (VTE) in patients who have a transient provoking factor (e.g., surgery, trauma, or immobility) and concomitant enduring risk ...
Researchers conducted a cross-sectional study to examine hepatitis B treatment trends among adults in the United States.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results